A large-scale functional study identified 71 newly confirmed oncogenic variants among 160 FGFR mutations; FGFR2 mutations in endometrial cancer significantly correlate with molecular subtypes, showing markedly elevated frequency in microsatellite instability-high (MSI-H) tumors [77]. This evidence concerns the gene FGFR2 and endometrial cancer.